Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials

JAMA Intern Med. 2019 Apr 1;179(4):582-584. doi: 10.1001/jamainternmed.2018.7661.

Abstract

This study evaluates the inclusion of studies identified by the FDA as having falsified data in the results of meta-analyses.

Publication types

  • Meta-Analysis
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Anticoagulants / pharmacology
  • Clinical Trials as Topic / methods*
  • Drug Approval / methods*
  • Drug Evaluation / methods*
  • Humans
  • Pyrazoles / pharmacology*
  • Pyridones / pharmacology*
  • United States
  • United States Food and Drug Administration*

Substances

  • Anticoagulants
  • Pyrazoles
  • Pyridones
  • apixaban